MRI in Ductal Carcinoma in Situ (DCIS)
Relevance of Mammary MRI in the Preoperative Assessment of Ductal Carcinoma in Situ (DCIS)
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Marie Noëlle ROEDLICH, MD
- Phone Number: 33 3 88 12 78 42
- Email: marie-noelle.roedlich@chru-strasbourg.fr
Study Contact Backup
- Name: Claire DETTLOFF, MD
- Phone Number: 33 3 88 12 78 42
- Email: claire.dettloff@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France, 67098
- Recruiting
- Service de Radiologie 1
-
Contact:
- Marie Noëlle ROEDLICH, MD
- Phone Number: 33 3 88 12 78 42
- Email: marie-noelle.roedlich@chru-strasbourg.fr
-
Contact:
- Claire DETTLOFF, MD
- Phone Number: 33 3 88 12 78 42
- Email: claire.dettloff@chru-strasbourg.fr
-
Principal Investigator:
- Marie Noëlle ROEDLICH, MD
-
Sub-Investigator:
- Claire DETTLOFF, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥18 ans
- Woman with DCIS
Exclusion Criteria:
- Age ≥18 ans)
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The investigators compare the estimate of the lesional size in MRI to that in mammography, taking as a reference the definitive anatomo-pathological size
Time Frame: The period from January 1st, 2017 to December 31st, 2017 will be examined]
|
Patients hospitalized at Strasbourg University Hospital in 2017
|
The period from January 1st, 2017 to December 31st, 2017 will be examined]
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Marie Noëlle ROEDLICH, MD, University Hospital, Strasbourg, France
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 7013
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.